Nasdaq:MESO

Mesoblast Announces Changes to Board of Directors’ Leadership Roles

January 01, 2026 18:02 ET  | Source: Mesoblast Limited NEW YORK, Jan. 01, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;…

4 hours ago

Mesoblast Retires Senior Debt with Non-Dilutive, Lower Cost, Five-Year Credit Line

December 29, 2025 18:57 ET  | Source: Mesoblast Limited Mesoblast has option to draw down up to US$125 million by…

4 days ago

Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD

December 11, 2025 18:22 ET  | Source: Mesoblast Limited NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;…

3 weeks ago